Innoviva, Inc. - 23 Jan 2026 SCHEDULE 13D/A Report for Armata Pharmaceuticals, Inc. Common Stock, $0.01 par value (ARMP)

Filing Manager
Innoviva, Inc.
Reporting Manager
Innoviva, Inc.
Security
Armata Pharmaceuticals, Inc. Common Stock, $0.01 par value
Symbol
ARMP
Shares outstanding
66,747,845 shares
Disclosed Ownership
55,467,459 shares
Ownership
83%
Form type
SCHEDULE 13D/A
Filing time
26 Jan 2026, 16:05:33 UTC
Date of event
23 Jan 2026
Previous filing
12 Aug 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Innoviva, Inc. 83% 55,467,459 8,710,800 46,756,659 /s/ Pavel Raifeld Pavel Raifeld, Chief Executive Officer 0001080014
Innoviva Strategic Opportunities LLC 70% 46,756,659 16,365,969 46,756,659 /s/ Pavel Raifeld Pavel Raifeld, Chief Executive Officer 0001842875